References
- Morris, J. R.; Samano, V.; Johnson, M. D. Nucleic acid-related compounds. 58. Periodinane oxidation, selective primary deprotection, and remarkably stereoselective reduction of tert-butyldimethylsilyl-protected ribonucleosides. Synthesis of 9-(.beta.-D-xylofuranosyl)adenine or 3′-deuterioadenosine from adenosine. J. Org. Chem. 1990, 55, 410–412.
- Elgemeie, G. H., Thioguanine, mercaptopurine, their analogs, and nucleosides as antimetabolites, Curr. Pharm. Design, Bentham Science Publishers, Exceutive Editor: Elgemeie, G.H., USA. 2003, 9, 2627–2642.
- Elgemeie, G. H.; Abou-Zeid, M.; Alsaid, S.; Hebishy, A.; Essa, H. Novel nucleoside analogues, first synthesis of pyridine 4-thioglycosides and their cytotoxic evaluation, Nucleosides & Nucleotides. 2015, 34, 659–673.
- Abu-Zaied, M. A.; El-Telbani, E. M.; Elgemeie, G. H.; Nawwar, G. A. M. Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides. Eur. J. Med. Chem. 2001, 46, 229–235.
- Zbigniew, J. W.; Peter, K.; Markus, P. D. Thio sugars VII. Effect of 3-deoxy-4-S-(β-D-gluco- and β-D-galactopyranosyl)-4-thiodisaccharides and their sulfoxides and sulfones on the viability and growth of selected murine and human tumor cell lines. Carbohydr. Res. 2003, 338, 11–18.
- Scale, S.; Akhmed, N.; Rao, U. S.; Paul, K.; Lan, L.; Dickstein, B.; Lee, J.; Elgemeie, G. H.; Stein, W. D.; Bates, S. E. P-Glycoprotein substrates and antagonists cluster into two distinct groups, Molecular Pharmacology. 1997, 51, 1024–1032.
- Elgemeie, G. H.; Farag, A. B. Design, synthesis, and in vitro anti hepatocellular carcinoma of novel thymine thioglycoside analogs as new antimetabolic agents, Nucleosides & Nucleotides. 2017, 36, 328–342.
- Dwek, R. A. Glycobiology: Toward understanding the function of sugars. Chem. Rev. 1996, 96, 683–720.
- Minko, T.; Dharap, S. S.; Pakunlu, R. I.; Wang, Y. Molecular targeting of drug delivery systems to cancer, Curr. Drug targets. 2004, 5, 389–406.
- Zhong, W.; Moya, C.; Jacobs, R. S.; Little, R. D. Synthesis and an evaluation of the bioactivity of the C-Glycoside of pseudopterosin a methyl ether., J. Org. Chem. 2008, 73, 7011–7016.
- Shao, H.; Wang, Z.; Lacroix, E.; Wu, S. H.; Jennings, H. J.; Zou, W. Novel Zinc (II)-Mediated Epimerization of 2‘-Carbonylalkyl-α-C-glycopyranosides to Their β-Anomers. J. Am. Chem. Soc. 2002, 124, 2130–2131.
- Peter, N. Pyranose N-Glycosyl Amines: Emerging Targets With Diverse Biological Potential, Curr. Top. Med. Chem. 2008, 8, 101–113.
- Kren, V.; Martinkova, L. Glycosides in Medicine: “The Role of Glycosidic Residue in Biological Activity.” Curr. Med. Chem. 2001, 8, 1313–1338.
- Elgemeie, G. H.; Abou-Zeid, M.; Azzam, R. Antimetabolites: A first synthesis of a new class of cytosine thioglycoside analogs, Nucleosides & Nucleotides. 2016, 35, 211–222.
- Elgemeie, G. H.; Salah, A. M.; Abbas, N. S.; Hussein, H. A.; Mohamed, R. A. Nucleic acid components and their analogs: design and synthesis of novel cytosine thioglycoside analogs, Nucleosides & Nucleotides. 2017, 36, 139–150.
- Elgemeie, G. H.; Fathy, N.; Zaghary, W.; Farag, A. S-Glycosides in medicinal chemistry: novel synthesis of cyanoethylene thioglycosides and their pyrazole derivatives, Nucleosides & Nucleotides. 2017, 36, 198–212.
- Elgemeie, G. H.; Fathy; Farag, A. Al-Khursani, Antimetabolites: design, synthesis, and cytotoxic evaluation of novel dihydropyridine thioglycosides and pyridine thioglycosides, Nucleosides & Nucleotides. 2017, 36, 355–377.